NGM·Healthcare·$310M·#418 / 520 in Healthcare
ACIU AC Immune SA
26HIGH RISK
CATEGORY BREAKDOWN
GROWTH0
QUALITY0
STABILITY36
VALUATION0
GOVERNANCE100
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-86.9%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
5 months
8
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
10.1%
92
< 25% strong
Price / Sales
Market cap relative to trailing revenue
86.7x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-2014
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
37.9%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-8.7%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ACIU WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when ACIU's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.